Management of haemophilia patients in the COVID‐19 pandemic: Experience in Wuhan and Tianjin, two differently affected cities in China

To identify lessons learned from haemophilia care experience in Wuhan (COVID‐19 outbreak epicenter in China) and Tianjin (with relatively low COVID‐19 incidence) in the pandemic.

[1]  M. Roser,et al.  Coronavirus Pandemic (COVID-19) , 2020 .

[2]  L. Valentino,et al.  The role of telemedicine in the delivery of health care in the COVID‐19 pandemic , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  C. Hermans,et al.  In‐hospital management of persons with haemophilia and COVID‐19: Practical guidance , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[4]  Yadan Wang,et al.  Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan , 2020, The Lancet Oncology.

[5]  A. Weill,et al.  The COVID‐19 pandemic: New global challenges for the haemophilia community , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  Q. Hu,et al.  Clinical findings in a patient with haemophilia A affected by COVID‐19 , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[7]  R. Agha,et al.  World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) , 2020, International Journal of Surgery.

[8]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[9]  M. Poon,et al.  Healthcare professionals in the ‘tainted blood’ era in Canada: Their forgotten emotions , 2019, Haemophilia : the official journal of the World Federation of Hemophilia.